| 2025年年报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 会展业务(元) | 57,972,623.74 | 70,245,750.09 | 34,052,574.42 |
| 商业运营(元) | 130,249,151.57 | 188,341,918.76 | 96,086,587.49 |
| 药品(元) | 702,665,381.49 | 790,630,187.56 | 429,740,014.81 |
| 医疗器械(元) | 76,013,649.26 | 82,574,608.46 | 37,719,630.24 |
| 其他(元) | 64,789,087.95 | 43,609,316.00 | 28,356,119.12 |
| 营业成本(元) | |||
| 会展业务(元) | 3,630,038.63 | 3,329,537.77 | 955,475.58 |
| 商业运营(元) | 28,700,119.88 | 48,523,891.38 | 21,113,894.07 |
| 药品(元) | 461,281,246.00 | 430,685,363.44 | 239,483,351.26 |
| 医疗器械(元) | 21,380,804.96 | 12,967,867.05 | 6,205,892.72 |
| 其他(元) | 25,072,192.12 | 21,085,263.11 | 11,780,145.79 |
| 毛利(元) | |||
| 会展业务(元) | 54,342,585.11 | 66,916,212.32 | 33,097,098.84 |
| 商业运营(元) | 101,549,031.69 | 139,818,027.38 | 74,972,693.42 |
| 药品(元) | 241,384,135.49 | 359,944,824.12 | 190,256,663.55 |
| 医疗器械(元) | 54,632,844.30 | 69,606,741.41 | 31,513,737.52 |
| 其他(元) | 39,716,895.83 | 22,524,052.89 | 16,575,973.33 |
| 毛利率(%) | |||
| 会展业务(%) | 93.74 | 95.26 | 97.19 |
| 商业运营(%) | 77.97 | 74.24 | 78.03 |
| 药品(%) | 34.35 | 45.53 | 44.27 |
| 医疗器械(%) | 71.87 | 84.30 | 83.55 |
| 其他(%) | 61.30 | 51.65 | 58.46 |
| 收入构成(%) | |||
| 会展业务(%) | 5.62 | 5.98 | 5.44 |
| 商业运营(%) | 12.62 | 16.02 | 15.35 |
| 药品(%) | 68.11 | 67.26 | 68.65 |
| 医疗器械(%) | 7.37 | 7.03 | 6.03 |
| 其他(%) | 6.28 | 3.71 | 4.53 |
| 毛利构成(%) | |||
| 会展业务(%) | 11.05 | 10.16 | 9.55 |
| 商业运营(%) | 20.66 | 21.22 | 21.64 |
| 药品(%) | 49.10 | 54.64 | 54.92 |
| 医疗器械(%) | 11.11 | 10.57 | 9.10 |
| 其他(%) | 8.08 | 3.42 | 4.78 |